D. V. van Veldhuisen

Publications799
h-index109
Citations50,994
Highly Influential Citations1,614
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Voors
  • 791 Publications, 38,093 Citations
  • P. Ponikowski
  • 752 Publications, 45,636 Citations
  • J. McMurray
  • 1,090 Publications, 80,244 Citations
  • C. O'Connor
  • 1,137 Publications, 62,877 Citations
  • Publications
  • Influence
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].
Authors/Task Force Members: Silvia G. Priori* (Chairperson) (Italy), Carina Blomström-Lundqvist* (Co-chairperson) (Sweden), Andrea Mazzanti† (Italy), Nico Blom (The Netherlands), Martin Borggrefe… Expand
  • 1,452
  • 99
  • PDF
Eplerenone in patients with systolic heart failure and mild symptoms.
BACKGROUND Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart failure after myocardial infarction. We evaluated the effects of… Expand
  • 2,048
  • 69
  • PDF
Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis
Objective: To assess the association of depression following myocardial infarction (MI) and cardiovascular prognosis. Methods: The authors performed a meta-analysis of references derived from… Expand
  • 944
  • 47
  • PDF
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AGNES : Arrhythmia Genetics in the Netherlands AHA : American Heart… Expand
  • 1,027
  • 41
  • PDF
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
AIMS Large randomized trials have shown that beta-blockers reduce mortality and hospital admissions in patients with heart failure. The effects of beta-blockers in elderly patients with a broad range… Expand
  • 1,296
  • 36
  • PDF
Rosuvastatin in older patients with systolic heart failure.
BACKGROUND Patients with systolic heart failure have generally been excluded from statin trials. Acute coronary events are uncommon in this population, and statins have theoretical risks in these… Expand
  • 947
  • 35
Outcome of pregnancy in women with congenital heart disease: a literature review.
A search of peer-reviewed literature was conducted to identify reports that provide data on complications associated with pregnancy in women with structural congenital heart disease (CHD). This… Expand
  • 460
  • 33
  • PDF
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Abstract Aims. Galectin-3 is an emerging biomarker which has been studied in relatively small heart failure (HF) cohorts with predominantly systolic HF. We studied the prognostic value of base-line… Expand
  • 458
  • 28
  • PDF
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
PURPOSE The purpose of this analysis was to investigate trastuzumab-associated cardiac adverse effects in breast cancer patients after completion of (neo)adjuvant chemotherapy with or without… Expand
  • 488
  • 24
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†
Aim The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy in iron-deficient patients with heart failure (HF). Methods and results CONFIRM-HF was a multi-centre,… Expand
  • 529
  • 23
  • PDF